Abiopharma

Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 HORIZON Study of TNX-102 SL for the Treatment of Major Depressive Disorder (MDD)

Dyadic Expands IP Protection and Business Development Activities in Japan

Net Asset Value(s)

Private placement of 430,835 to employees, officers and CEO

Financial Statements and Related Announcement: Full Yearly Results

FORM 6-K- Investor Presentation - June 2026

Martin Marietta to Combine with Lhoist North America in $13.5 Billion Transaction

Honeywell Aerospace completes spin-off from Honeywell Technologies and begins trading on Nasdaq

Compass Minerals Announces S&P Global Ratings Upgrade to B+

Keel Infrastructure Added to Russell 3000® Index